Las Vegas, NV -- (SBWIRE) -- 12/24/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), The Procter & Gamble Company (NYSE:PG), CorMedix Inc. (NYSEMKT:CRMD), Forest Oil Corporation (NYSE:FST)
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) managed to keep its gain at 4.86% on above-normal volume of 1.24M shares. The stock settled at $2.59 after floating in a range of $2.49 to $2.62. Its latest price has reached market capitalization of $22.44 million. Its 52-week range has been $2.31 to $7.61. Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company discovers and develops small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders.
For How Long RIGL will fight for Profitability? Read This Trend Analysis report
The Procter & Gamble Company (NYSE:PG) traded down on a volume of 8.86 million, higher than its standard daily volume. Shares have dropped-0.65% to $81.31. Over the last twelve months, the stock has gained 18.32% and faced a worst price of $66.83. The Procter & Gamble Company (P&G) is focused on providing consumer packaged goods. The Company’s products are sold in more than 180 countries and territories worldwide primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, salons, e-commerce and high-frequency stores, and the neighborhood stores, which serve many consumers in developing markets. As of June 30, 2013, the Company had five reportable segments.
Has PG Found The Bottom And Ready To Gain Momentum? Find Out Here
CorMedix Inc. (NYSEMKT:CRMD) settled 33.72% higher at $1.15 on above-normal volume of 1.22M shares during the last trading day. The stock has its 12-month high at $1.37 and 52-week low price was $0.48. It traded in a range of $0.91 to $1.37 during the last trading day. CorMedix Inc. (CorMedix) is a biopharmaceutical company that focuses on in-licensing, developing and commercializing therapeutic products for the treatment of cardiac and renal dysfunction, also know as Cardiorenal disease. The Company has licensed all of the products in its Cardiorenal pipeline.
Why Should Investors Buy CRMD After the Recent Fall? Just Go Here and Find Out
In the last trading session, Forest Oil Corporation(NYSE:FST) showed no change on low volume, trading at a volume of 2.61M shares versus its average daily volume of 3.97 million shares. At $3.76, the stock has attained market capitalization of $449.94 million. Forest Oil Corporation (Forest) is an independent oil and gas company engaged in the acquisition, exploration, development, and production of oil, natural gas, and natural gas liquids in North America.
Can FST Show a Strong Recovery? Find out in This Research Report
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)